Clinical Trial Update: Long-term Safety Study for GSK573719 in Japanese [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of GSK573719 in Japanese patients with chronic obstructive pulmonary disease completed; results posted in August 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08